A recently introduced live-cell bone allograft may be a cost-effective alternative to autografts.
BioFuse provides a porous interconnected matrix for bone ingrowth, unlocking higher levels of osteoinductive biologic factors in comparison to traditional live-cell bone grafts, notes the manufacturer Extremity Medical.
Powered by WPeMatico